Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,387 | 12,874 | 23,088 | 20,943 | 18,047 |
| Marketable Securities | N/A | 22,268 | 22,675 | 18,236 | 35,977 |
| TOTAL | $25,030 | $36,802 | $46,857 | $40,085 | $55,974 |
| Non-Current Assets | |||||
| PPE Net | 258 | 333 | 436 | 318 | 409 |
| Investments And Advances | 0 | 0 | 2,221 | 21,459 | 16,206 |
| TOTAL | $258 | $333 | $2,657 | $21,777 | $16,615 |
| Total Assets | $25,288 | $37,135 | $49,514 | $61,862 | $72,589 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 246 | 719 | 1,063 | 702 | 1,621 |
| Accrued Expenses | 910 | 1,688 | 929 | 824 | 1,083 |
| Other current liabilities | 660 | N/A | N/A | N/A | N/A |
| TOTAL | $1,816 | $2,407 | $1,992 | $2,401 | $3,441 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,816 | $2,407 | $1,992 | $2,401 | $3,441 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 42 | 42 |
| Common Shares | 20 | 20 | 20 | 21 | 21 |
| Retained earnings | -180,362 | -153,935 | -140,812 | -129,573 | -119,109 |
| Other shareholders' equity | 15,556 | 0 | 0 | 0 | 0 |
| TOTAL | $23,472 | $34,728 | $47,522 | $59,461 | $69,148 |
| Total Liabilities And Equity | $25,288 | $37,135 | $49,514 | $61,862 | $72,589 |